Abu Dhabi Global Healthcare Week
September 4, 2024
Our Digistain® Clinical Validation Study Ranks in the 97th Percentile for Popularity
November 24, 2024
We are thrilled to share the announcement today that Digistain® are 1 of 4 FINALISTS for the 2024 Nature Spin-off Prize
Over 150 innovative technologies were diligently evaluated by a panel of scientists so we are very proud that our novel approach to breast cancer diagnostics has been recognised by this prestigious award panel.
Digistain was a finalist for the 2024 Nature Spin-off Prize.
